All
Novel HSF1 Pathway Inhibitor to Be Studied in Ovarian Carcinoma
A pharmaceutical company initiated a phase 1b study in patients with platinum-resistant, ARID1a-mutated ovarian carcinoma.
ChatGPT Can Answer Cancer Questions, But Clinician Input Still Vital
The use of ChatGPT (an artificial intelligence platform) tended to produce reliable cancer-related information in most circumstances, but patient-provider communication is still key, an expert said.
Sometimes Cancer Surveillance is Satisfactory
When survivorship becomes long-term, it can be an adjustment to move from active treatment to periodic surveillance.
My Journey with Oral Cancer
I had what I thought was a canker sore that didn't heal. It ended up being cancer.
Keytruda/Lenvima Trials Stop Due to Lack of Benefit
Two clinical trials investigating Keytruda plus Lenvima will be discontinued after the drug duo was not superior to other regimens for melanoma and colorectal cancer subsets.
Cancer Taught Me There Are So Many Forms of Support
When I was first diagnosed, I wasn’t sure what kind of support to ask for, but now I’m thankful to have many wonderful forms of support around me.
Cancer Imposter Syndrome
After hearing others' cancer stories, I found myself feeling "less than" because I didn't undergo radiation and chemotherapy.
Standard Treatment May Not Be Best for Exon 20-Mutant Lung Cancer
Rybrevant outperformed other therapies for patients with exon 20 insertion-mutant, advanced non-small cell lung cancer in a clinical trial, highlighting the importance of personalized medicine.
Pharma Companies Pull Imbruvica Indication for Marginal Zone and Mantle Cell Lymphoma
Long-term data showed that the addition of Imbruvica did not improve overall survival in patients with marginal zone lymphoma or mantle cell lymphoma.
Elahere Symptoms Patients With Ovarian Cancer Should Look Out For
There are certain side effects from Elahere — a newly approved ovarian cancer drug — that patients taking the treatment should look out for, an expert said.
Lessons From Cancer Survivorship
Nowadays, I think of myself more as a cancer survivor and advocate than patient. Here's what I learned along the way.
Fleetwood Mac Singer Died of Stroke and Cancer; Hugh Jackman Urges for Skin Cancer Checks and More
From the reveal of Christine McVie’s cause of death to cancer news from Hugh Jackman and a U.S. congressman, here’s what’s happening in the oncology space this week.
Keytruda Plus Chemo May Not Worsen Quality of Life in Subset of Patients With Cervical Cancer
This analysis of the KEYNOTE-826 trial focused on health-related quality of life in patients with persistent, recurrent or metastatic cervical cancer.
How I went from ‘Person’ to ‘Patient’
The day I got diagnosed with cancer, I went from “person” to “patient” — and the title has followed me ever since.
Social Media Can Connect Both Patients With Rare Cancers and Researchers
Social media, including Facebook groups, can help connect patients with rare cancers like granulosa cell tumors to researchers, allowing them to learn more about disease management.
What to Accept — and What Not to — During Cancer
After being diagnosed with aggressive bone cancer, I had to accept that much of my life was going to change.
Opdivo Before Surgery May Improve 5-Year Survival in NSCLC
Immunotherapy treatment with Opdivo before surgery improved recurrence-free survival and overall survival at five years in patients with non-small cell lung cancer.
Lynparza/Imfinzi Regimen Is ‘Encouraging’ for Advanced Ovarian Cancer
Interim findings from a clinical trial showed that adding Lynparza and Imfinzi to an Avastin and chemotherapy regimen tended to improve the time patients lived before their disease got worse.
Earlier Lymphedema Detection May Lead to Better Outcomes
When a green dye was used to detect early signs of breast cancer-related lymphedema, patients tended to have better outcomes with the condition, recent research showed.
HER3-DXd Promising for Breast Cancer Type With ‘Poor Prognosis’
HER3-DXd proved to be safe and efficacious in treating patients with HER3-expressing metastatic breast cancer, recent study results showed.
Patient Experiences With Medical Marijuana for Cancer Symptoms
Patients and cancer survivors shared their experiences with cannabis/medical marijuana to help relieve symptoms.
Self-Advocacy in Cancer Care Is Vital, Though Often Uncomfortable
I learned that self-advocacy is not about proving an oncology wrong or deciding that one drug is better than the other. It’s about speaking up for what you think is right.
Prostate Cancer Drug Shortage: What Patients Need to Know
A prostate cancer expert lends insight to the nationwide Pluvicto shortage, and what eligible patients can do.
FDA to Review Drug Duo for BRAF-Mutant Lung Cancer
The Food and Drug Administration will review Braftovi plus Mektovi for the treatment of patients with metastatic BRAF V600E-mutant non-small cell lung cancer.
You Are What You Think: Staying Optimistic During Cancer
While I wouldn’t say that my cancer-related hospital stays were fun, I did my best to maintain a positive attitude and make the best of them.
Cold Compression May Prevent Chemo-Induced Neuropathy
Cryocompression was found to be tolerable and effective in preventing chemotherapy-induced peripheral neuropathy in a small study.
The Big White Cancer Binder
Sometimes, hundreds of pages of cancer information still just doesn’t connect with the person who needs it.
Long-Term Prostate Cancer Outcomes May Not Differ by Treatment Type
Researchers determined that mortality rates did not differ in men with localized prostate cancer if they underwent active monitoring, prostatectomy or radiotherapy.
Novel CAR-T Cell Therapy to Be Studied in Blood, Breast Cancers
A phase 1/1b trial will examine PRGN-3007 in patients with ROR1-positive hematologic and solid cancers.
FDA Approves Padcev-Keytruda Combo for Advanced Bladder Cancer
The FDA approved the combination for patients with locally advanced or metastatic urothelial carcinoma who are ineligible for treatment with cisplatin-based chemotherapy.
